Intellia Therapeutics Stock (NASDAQ: NTLA) stock price, news, charts, stock research, profile.
Open | $25.000 |
Close | $24.460 |
Volume / Avg. | 2.043M / 1.488M |
Day Range | 24.220 - 25.421 |
52 Wk Range | 19.370 - 47.480 |
Market Cap | $2.343B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 54 |
Short Interest | 17.36% |
Days to Cover | 11.57 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Intellia Therapeutics (NASDAQ: NTLA) through any online brokerage.
Other companies in Intellia Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX), TG Therapeutics (NASDAQ:TGTX) and PTC Therapeutics (NASDAQ:PTCT).
The latest price target for Intellia Therapeutics (NASDAQ: NTLA) was reported by Citigroup on Friday, May 10, 2024. The analyst firm set a price target for 29.00 expecting NTLA to rise to within 12 months (a possible 19.34% upside). 23 analyst firms have reported ratings in the last year.
The stock price for Intellia Therapeutics (NASDAQ: NTLA) is $24.3 last updated May 10, 2024 at 5:54 PM EDT.
There are no upcoming dividends for Intellia Therapeutics.
Intellia Therapeutics’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Intellia Therapeutics.
Intellia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.